Table 6. Summary of clinical signs in the NaOCl inhalation group.
| Sex | Clinical signs | Concentrations (mg/L) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.22 | 0.67 | 2.00 | ||||||
| aa | bb | aa | bb | aa | bb | aa | bb | ||
| Male | No abnormalities detected | 5 | 15.00 | 5 | 14.40 | 5 | 12.20 | 5 | 5.00 |
| Irregular respiration | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 3 | 2.67 | |
| Female | No abnormalities detected | 5 | 15.00 | 5 | 15.00 | 5 | 13.20 | 5 | 9.80 |
| Irregular respiration | 0 | 0.00 | 0 | 0.00 | 0 | 0.00 | 2 | 3.00 | |
NaOCl, sodium hypochlorite.
aNumber of rats affected; bMean number of days with observed clinical signs.